Literature DB >> 27757529

Efficacy of Yeast' Vacuoles as Antimicrobial Agents to Escherichia coli Bacteremia in Rat.

Jihee Yoon1, Ho-Seong Cho2, Chul Park2, Byoung-Yong Park2, Yang-Hoon Kim3, Jiho Min4.   

Abstract

Yeast vacuoles, lysosomes, are cell organelles that have antimicrobial activity against several bacteria in vitro. Lysosomes have a potential application to the treatment of pathogens such as antibiotics in vivo. Therefore, the in vivo efficacy of lysosomes was examined in a rat infection model against pathogenic Escherichia coli with varying susceptibilities to standard antimicrobial agents. Before in vivo testing, the concentration-dependent safety of lysosomes was confirmed by blood test and histopathology of normal rats. The therapeutic efficacy of lysosomes was examined in terms of the survival of E. coli in infected rat blood. The complete blood count and histopathology results were affected by the lysosomes concentration. In addition, the E. coli growth was inhibited by the initial injection of lysosomes. These results support the use of lysosomes as a bacterial inhibitor of an infected rat model.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27757529     DOI: 10.1007/s00284-016-1146-1

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  24 in total

1.  Innate immunity. Ancient system gets new respect.

Authors:  T Gura
Journal:  Science       Date:  2001-03-16       Impact factor: 47.728

Review 2.  Regulating secretory lysosomes.

Authors:  Oliver J Holt; Federico Gallo; Gillian M Griffiths
Journal:  J Biochem       Date:  2006-07       Impact factor: 3.387

3.  Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Authors:  J D Heffelfinger; S F Dowell; J H Jorgensen; K P Klugman; L R Mabry; D M Musher; J F Plouffe; A Rakowsky; A Schuchat; C G Whitney
Journal:  Arch Intern Med       Date:  2000-05-22

4.  Comparative in vivo activity of gemifloxacin in a rat model of respiratory tract infection.

Authors:  V Berry; R Page; J Satterfield; C Singley; R Straub; G Woodnutt
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

5.  Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes.

Authors:  A D Glick; J M Ranhand; R M Cole
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

6.  Antibiotics that resist resistance.

Authors:  R F Service
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

7.  Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.

Authors:  Shiri Navon-Venezia; Rina Feder; Leonid Gaidukov; Yehuda Carmeli; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.

Authors:  David C Griffith; Laurie Harford; Robert Williams; Ving J Lee; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Characterization of antimicrobial activity of the lysosomes isolated from Saccharomyces cerevisiae.

Authors:  Jihee Yoon; Jae-Min Park; Seung-Ki Jung; Keun-Young Kim; Yang-Hoon Kim; Jiho Min
Journal:  Curr Microbiol       Date:  2009-03-25       Impact factor: 2.188

10.  Mutant defective in processing of an enzyme located in the lysosome-like vacuole of Saccharomyces cerevisiae.

Authors:  B A Hemmings; G S Zubenko; A Hasilik; E W Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  2 in total

1.  Genotoxic Escherichia coli Strains Encoding Colibactin, Cytolethal Distending Toxin, and Cytotoxic Necrotizing Factor in Laboratory Rats.

Authors:  Susanna A Kurnick; Anthony J Mannion; Yan Feng; Carolyn M Madden; Paul Chamberlain; James G Fox
Journal:  Comp Med       Date:  2019-03-22       Impact factor: 0.982

2.  Specific histamine regulating activity of surface-modified yeast vacuoles by histamine- binding protein and its immune-enhancing effect.

Authors:  Hyeweon Jang; Yang-Hoon Kim; Jiho Min
Journal:  Microb Biotechnol       Date:  2022-08-10       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.